8-K//Current report
Seres Therapeutics, Inc. 8-K
Accession 0001193125-25-230118
$MCRBCIK 0001609809operating
Filed
Oct 2, 8:00 PM ET
Accepted
Oct 3, 4:06 PM ET
Size
137.8 KB
Accession
0001193125-25-230118
Documents
- 8-Kd63317d8k.htmPrimary
8-K
- EX-101.SCHmcrb-20250923.xsd
XBRL TAXONOMY EXTENSION SCHEMA
- EX-101.LABmcrb-20250923_lab.xml
XBRL TAXONOMY EXTENSION LABEL LINKBASE
- EX-101.PREmcrb-20250923_pre.xml
XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
- XMLR1.htm
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001193125-25-230118-xbrl.zip
IDEA: XBRL DOCUMENT
- XMLd63317d8k_htm.xml
IDEA: XBRL DOCUMENT
Issuer
Seres Therapeutics, Inc.
CIK 0001609809
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001609809
Filing Metadata
- Form type
- 8-K
- Filed
- Oct 2, 8:00 PM ET
- Accepted
- Oct 3, 4:06 PM ET
- Size
- 137.8 KB